Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Journal of Bioactive and Compatible Polymers
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Pandit, A.
Right arrow Articles by Thompson, A.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The Effect on Wound Healing by a Modified Fibrin Scaffold Delivering Acidic Fibroblast Growth Factor (FGF-1)

Abhay Pandit

University of Alabama at Birmingham, Birmingham, AL 35294

Dale Feldman

University of Alabama at Birmingham, Birmingham, AL 35294

Catherine Listinsky

University of Alabama at Birmingham, Birmingham, AL 35294

Anthony Thompson

University of Alabama at Birmingham, Birmingham, AL 35294

This project investigated the efficacy of modified fibrin scaffold as a vehicle for acidic fibroblast growth factor (FGF-1). The goal of this study was to justify the use of a modified fibrin scaffold with altered surface roughness and porosity as a drug-delivery matrix, specifically for the delivery of FGF-1. The hypothesis tested was that FGF-1 delivered in an optimal dose through a modified fibrin scaffold would result in a significant increase in angiogenesis, epithelialization, fibroblast, and healing rate, and correspond to a decrease in overall healing time. In vivo testing was conducted in a full-thickness defect model in a rabbit. Four 3 x 3-cm full-thickness defects were created on the dorsum of each of five white New Zealand rabbits. There were four treatments to be investigated: modified fibrin scaffold, modified fibrin/FGF-1 scaffolds, topical FGF-1, and control defects. The regimen of topical dosing of FGF-1 was determined from release kinetic studies using the modified fibrin scaffold. The areas and perimeters of the initial wound and final wounds were obtained from histological slides using an image analysis system. Standard histomorphometric techniques were used to characterize the wound-healing response. In this study, the modified fibrin/FGF-1 scaffold served as a suitable vehicle for FGF-1, providing an enhanced angiogenic and a fibroblastic healing response and, thus, was found to be an effective scaffold.

Journal of Bioactive and Compatible Polymers, Vol. 12, No. 2, 99-111 (1997)
DOI: 10.1177/088391159701200202


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?